North Run Capital’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$186K Hold
443,730
0.43% 23
2022
Q3
$346K Sell
443,730
-15,000
-3% -$15.8K 0.7% 24
2022
Q2
$587K Sell
458,730
-465,770
-50% -$614K 1.2% 19
2022
Q1
$1.3M Sell
924,500
-196,900
-18% -$421K 1.92% 16
2021
Q4
$3.05M Buy
+1,121,400
New +$4.13M 2.34% 16
2021
Q2
Sell
-40,000
Closed -$321K 22
2021
Q1
$321K Sell
40,000
-110,000
-73% -$1.02M 0.24% 18
2020
Q4
$1.34M Sell
150,000
-282,300
-65% -$2.35M 1.56% 16
2020
Q3
$3.25M Buy
432,300
+62,513
+17% +$433K 3.76% 11
2020
Q2
$2.36M Buy
369,787
+167,287
+83% +$1.12M 3.23% 14
2020
Q1
$1.5M Buy
202,500
+46,500
+30% +$360K 1.51% 21
2019
Q4
$1.41M Sell
156,000
-319,000
-67% -$2.68M 1.11% 19
2019
Q3
$3.56M Buy
475,000
+75,000
+19% +$421K 2.68% 15
2019
Q2
$2.08M Buy
400,000
+200,000
+100% +$1.3M 1.41% 21
2019
Q1
$1.67M Buy
+200,000
New +$1.44M 1.07% 22

Other funds holding IVC

North Run Capital's IVC Position: Q4 2022 in Review

North Run Capital held its Invacare Corporation (IVC) position steady in Q4 2022 at 443,730 shares worth $186K. The position accounts for 0.43% of the portfolio, ranked #23.

North Run Capital first reported a position in IVC in Q1 2019 and has held it in 14 quarters since. The position peaked at $3.56M in Q3 2019. 66 funds tracked by Wall St. Rank hold IVC as of Q4 2022.

  • North Run Capital held 443,730 shares of Invacare Corporation worth $186K as of Q4 2022.
  • North Run Capital left its Invacare Corporation share count unchanged in Q4 2022.
  • Invacare Corporation made up 0.43% of North Run Capital's portfolio in Q4 2022, its #23 holding.
  • North Run Capital first reported a position in Invacare Corporation in Q1 2019 and has held it in 14 quarters since.
  • North Run Capital's Invacare Corporation position peaked at $3.56M in Q3 2019.
  • 66 funds tracked by Wall St. Rank held Invacare Corporation as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.